Cargando…
Effective Delivery of Arsenic Trioxide to HPV-Positive Cervical Cancer Cells Using Optimised Liposomes: A Size and Charge Study
Despite the success of arsenic trioxide (ATO) in treating haematological malignancies, its potential to treat solid tumours has not been fully exploited, owing to its dose-limiting toxicity and poor pharmacokinetics. In order to overcome this hurdle, liposomal encapsulation of the drug with differen...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979440/ https://www.ncbi.nlm.nih.gov/pubmed/29617346 http://dx.doi.org/10.3390/ijms19041081 |
_version_ | 1783327697111351296 |
---|---|
author | Akhtar, Anam Wang, Scarlet Xiaoyan Ghali, Lucy Bell, Celia Wen, Xuesong |
author_facet | Akhtar, Anam Wang, Scarlet Xiaoyan Ghali, Lucy Bell, Celia Wen, Xuesong |
author_sort | Akhtar, Anam |
collection | PubMed |
description | Despite the success of arsenic trioxide (ATO) in treating haematological malignancies, its potential to treat solid tumours has not been fully exploited, owing to its dose-limiting toxicity and poor pharmacokinetics. In order to overcome this hurdle, liposomal encapsulation of the drug with different surface charges (neutral, negative, and positive) and sizes (100, 200 and 400 nm) were synthesised and tested on human papilloma virus (HPV)-positive HeLa and HPV-negative HT-3 cervical cancer cell lines. Two epithelial cell lines—human keratinocytes (HK) and human colon cells (CRL-1790)—were used as controls. The synthesised liposomes were tested for their physico-chemical characteristics, drug loading efficiency, and toxicity on the studied cell lines. Neutral liposomes of 100 nm in size were the chosen formulation for delivering ATO into the studied cells, as they showed the least intrinsic cytotoxicity and the highest loading efficiency. The findings demonstrated that the optimised formulation of liposomes was an effective drug delivery method for HPV-infected cervical cancer cells. Furthermore, the toxicity vs. uptake ratio was highest for HeLa cells, while a reduced or minimal toxic effect was observed for non-HPV-infected cervical cancer cells and control cells. These findings may provide a promising therapeutic strategy for effectively managing cervical cancers. |
format | Online Article Text |
id | pubmed-5979440 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-59794402018-06-10 Effective Delivery of Arsenic Trioxide to HPV-Positive Cervical Cancer Cells Using Optimised Liposomes: A Size and Charge Study Akhtar, Anam Wang, Scarlet Xiaoyan Ghali, Lucy Bell, Celia Wen, Xuesong Int J Mol Sci Article Despite the success of arsenic trioxide (ATO) in treating haematological malignancies, its potential to treat solid tumours has not been fully exploited, owing to its dose-limiting toxicity and poor pharmacokinetics. In order to overcome this hurdle, liposomal encapsulation of the drug with different surface charges (neutral, negative, and positive) and sizes (100, 200 and 400 nm) were synthesised and tested on human papilloma virus (HPV)-positive HeLa and HPV-negative HT-3 cervical cancer cell lines. Two epithelial cell lines—human keratinocytes (HK) and human colon cells (CRL-1790)—were used as controls. The synthesised liposomes were tested for their physico-chemical characteristics, drug loading efficiency, and toxicity on the studied cell lines. Neutral liposomes of 100 nm in size were the chosen formulation for delivering ATO into the studied cells, as they showed the least intrinsic cytotoxicity and the highest loading efficiency. The findings demonstrated that the optimised formulation of liposomes was an effective drug delivery method for HPV-infected cervical cancer cells. Furthermore, the toxicity vs. uptake ratio was highest for HeLa cells, while a reduced or minimal toxic effect was observed for non-HPV-infected cervical cancer cells and control cells. These findings may provide a promising therapeutic strategy for effectively managing cervical cancers. MDPI 2018-04-04 /pmc/articles/PMC5979440/ /pubmed/29617346 http://dx.doi.org/10.3390/ijms19041081 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Akhtar, Anam Wang, Scarlet Xiaoyan Ghali, Lucy Bell, Celia Wen, Xuesong Effective Delivery of Arsenic Trioxide to HPV-Positive Cervical Cancer Cells Using Optimised Liposomes: A Size and Charge Study |
title | Effective Delivery of Arsenic Trioxide to HPV-Positive Cervical Cancer Cells Using Optimised Liposomes: A Size and Charge Study |
title_full | Effective Delivery of Arsenic Trioxide to HPV-Positive Cervical Cancer Cells Using Optimised Liposomes: A Size and Charge Study |
title_fullStr | Effective Delivery of Arsenic Trioxide to HPV-Positive Cervical Cancer Cells Using Optimised Liposomes: A Size and Charge Study |
title_full_unstemmed | Effective Delivery of Arsenic Trioxide to HPV-Positive Cervical Cancer Cells Using Optimised Liposomes: A Size and Charge Study |
title_short | Effective Delivery of Arsenic Trioxide to HPV-Positive Cervical Cancer Cells Using Optimised Liposomes: A Size and Charge Study |
title_sort | effective delivery of arsenic trioxide to hpv-positive cervical cancer cells using optimised liposomes: a size and charge study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979440/ https://www.ncbi.nlm.nih.gov/pubmed/29617346 http://dx.doi.org/10.3390/ijms19041081 |
work_keys_str_mv | AT akhtaranam effectivedeliveryofarsenictrioxidetohpvpositivecervicalcancercellsusingoptimisedliposomesasizeandchargestudy AT wangscarletxiaoyan effectivedeliveryofarsenictrioxidetohpvpositivecervicalcancercellsusingoptimisedliposomesasizeandchargestudy AT ghalilucy effectivedeliveryofarsenictrioxidetohpvpositivecervicalcancercellsusingoptimisedliposomesasizeandchargestudy AT bellcelia effectivedeliveryofarsenictrioxidetohpvpositivecervicalcancercellsusingoptimisedliposomesasizeandchargestudy AT wenxuesong effectivedeliveryofarsenictrioxidetohpvpositivecervicalcancercellsusingoptimisedliposomesasizeandchargestudy |